SCHEMBL14655445

SCHEMBL14655445

NC(=O)[CH]C(=O)N1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
F2 P00734 1/20 0.39
ATM Q13315 1/20 0.36
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.34
PARP1 P09874 1/20 0.34
PARP15 Q460N3 1/20 0.34
PARP10 Q53GL7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5446634 0.98 ALDH1A1 (0.44) ALDH1A1F2MMP1MMP2MMP3
SCHEMBL14656015 0.95 ALDH1A1 (0.39) ALDH1A1F2ATMKMT2APARP1
SCHEMBL5971035 0.79 KDM4E (0.47) ALDH1A1MMP1MMP3SMN1; SMN2KDM4E
SCHEMBL17672298 0.76 ALDH1A1 (0.43) ALDH1A1F2HPGDSMN1; SMN2KMT2A
Acrylamide SCHEMBL10658901 0.75 ALDH1A1 (0.48) ALDH1A1F2MMP1MMP2MMP3
SCHEMBL22622465 0.73 ALDH1A1 (0.48) ALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL19502758 0.72 L3MBTL3 (0.49) ALDH1A1PARP1
SCHEMBL14655947 0.72 KCNH2 (0.34) ALDH1A1KDM4E
SCHEMBL1832187 0.70 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2KMT2A
SCHEMBL1706484 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518945-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-08-27 US claimed
EP-2550273-A2 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP claimed
US-8518945-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-08-27 US disclosed
EP-2550273-A2 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP disclosed